IDXXNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
IDEXX LABORATORIES INC /DE
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$555.80−4.56 (-0.81%)
Close on Oct 19, 2026
- Market cap
- $44.08B
- P/E (TTM)
- 39.1
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Jun 30, 2015 | 2-for-1 | Earlier per-share figures divided by 2 |
| Jun 16, 2015 | 2-for-1 | Earlier per-share figures divided by 2 |
| Nov 27, 2007 | 2-for-1 | Earlier per-share figures divided by 2 |
| Jun 6, 1995 | 2-for-1 | Earlier per-share figures divided by 2 |
| Oct 4, 1993 | 2-for-1 | Earlier per-share figures divided by 2 |